Yu‐Hua Hui

1.8k total citations
27 papers, 1.1k citations indexed

About

Yu‐Hua Hui is a scholar working on Biochemistry, Molecular Biology and Horticulture. According to data from OpenAlex, Yu‐Hua Hui has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Biochemistry, 7 papers in Molecular Biology and 7 papers in Horticulture. Recurrent topics in Yu‐Hua Hui's work include Traditional and Medicinal Uses of Annonaceae (9 papers), Cocoa and Sweet Potato Agronomy (7 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). Yu‐Hua Hui is often cited by papers focused on Traditional and Medicinal Uses of Annonaceae (9 papers), Cocoa and Sweet Potato Agronomy (7 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). Yu‐Hua Hui collaborates with scholars based in United States and Canada. Yu‐Hua Hui's co-authors include Jerry L. McLaughlin, J. Kent Rupprecht, Karl V. Wood, Kennan C. Marsh, David L. Smith, Jon E. Anderson, Clark A. Briggs, Michael Decker, Murali Gopalakrishnan and John A. Wijsman and has published in prestigious journals such as Cancer Research, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Yu‐Hua Hui

26 papers receiving 1.0k citations

Peers

Countries citing papers authored by Yu‐Hua Hui

Since Specialization

Citations

This map shows the geographic impact of Yu‐Hua Hui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Hua Hui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Hua Hui more than expected).

Fields of papers citing papers by Yu‐Hua Hui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Hua Hui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Hua Hui. The network helps show where Yu‐Hua Hui may publish in the future.

Co-authorship network of co-authors of Yu‐Hua Hui

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Hua Hui. A scholar is included among the top collaborators of Yu‐Hua Hui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Hua Hui. Yu‐Hua Hui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Aurora kinase A inhibitor, LY3295668 erbumine: a phase 1 monotherapy safety study in patients with locally advanced or metastatic solid tumors 2021 ·Investigational New Drugs ·Quincy S. Chu, Nathaniel Bouganim, (unknown), Sara Zaknoen, John R. Stille, Jill D. Kremer, Eunice Yuen, Yu‐Hua Hui, Amparo de la Peña, Andrew Lithio, Patricia S. Smith, Gerald Batist	19
2	An evaluation of metabolite profiling of six drugs using dried blood spot 2019 ·Xenobiotica ·(unknown), Yu‐Hua Hui	5
3	Abstract CT019: Population pharmacokinetics of an aurora kinase A inhibitor, LY3295668 erbumine (AK-01), in patients with locally advanced or metastatic solid tumors 2019 ·Cancer Research ·Eunice Yuen, Yu‐Hua Hui, Amparo de la Peña, Sonya C. Tate, John R. Stille, Andrew Lithio, Patricia S. Smith, Quincy S. Chu, Gerald Batist, Nathaniel Bouganim, (unknown), Sara Zaknoen, Jill D. Kremer	0
4	Abstract CT083: A Phase I/II study of aurora kinase A inhibitor, LY3295668 erbumine (AK-01): Safety as monotherapy in patients with locally advanced or metastatic solid tumors 2019 ·Cancer Research ·Quincy S. Chu, Nathaniel Bouganim, (unknown), Sara Zaknoen, John R. Stille, Jill D. Kremer, Eunice Yuen, Yu‐Hua Hui, Amparo de la Peña, Andrew Lithio, Patricia S. Smith, Gerald Batist	2
5	In Vitro and In Vivo Correlation of Hepatic Fraction of Metabolism by P450 in Dogs 2018 ·Journal of Pharmaceutical Sciences ·Xin Zhou, Yu‐Hua Hui, (unknown), (unknown), Michael A. Mohutsky, Junliang Hao, Douglas A. Schober, Erik J. Hembre	2
6	Utilizing¹⁹F NMR to investigate drug disposition early in drug discovery 2015 ·Xenobiotica ·Haitao Hu, (unknown), Ping Yi, Yu‐Hua Hui, Robert Dally, William J. Ehlhardt, Palaniappan Kulanthaivel	5
7	Identification of LY2510924, a Novel Cyclic Peptide CXCR4 Antagonist That Exhibits Antitumor Activities in Solid Tumor and Breast Cancer Metastatic Models 2014 ·Molecular Cancer Therapeutics ·Sheng-Bin Peng, Xiaoyi Zhang, Donald C. Paul, Lisa Kays, Wendy H. Gough, Julie Stewart, Mark Uhlik, Qi Chen, Yu‐Hua Hui, Maciej J. Zamek‐Gliszczynski, John A. Wijsman, Kelly M. Credille, Liang Yan	116
8	Pharmacokinetic comparisons of tail-bleeding with cannula- or retro-orbital bleeding techniques in rats using six marketed drugs 2007 ·Journal of Pharmacological and Toxicological Methods ·Yu‐Hua Hui, (unknown), (unknown), Holly A. Bina, Alan Y. Chiang, (unknown), (unknown), (unknown), Nita Patel	52
9	Proteomic Analysis of Rat Liver Phosphoproteins after Treatment with Protein Kinase Inhibitor H89 (N-(2-[p-Bromocinnamylamino-]ethyl)-5-isoquinolinesulfonamide) 2006 ·Journal of Pharmacology and Experimental Therapeutics ·Myrtle A. Davis, Douglas Hinerfeld, (unknown), Yu‐Hua Hui, (unknown), John Leszyk, (unknown), Sun W. Tam	15
10	Discovery, SAR, synthesis, pharmacokinetic and biochemical characterization of A-192411: A novel fungicidal lipopeptide-(I) 2003 ·Bioorganic & Medicinal Chemistry Letters ·Weibo Wang, Qun Li, Lisa Hasvold, (unknown), Daniel A. Dickman, Hong Ding, (unknown), Hui-Ju Chen, David J. Frost, Robert C. Goldman, Kennan C. Marsh, Yu‐Hua Hui, Brian J. Cox, Angela M. Nilius, (unknown), Paul A. Lartey, Jacob J. Plattner, Youssef L. Bennani	8
11	Modeling of Relationships between Pharmacokinetics and Blockade of Agonist-Induced Elevation of Intraurethral Pressure and Mean Arterial Pressure in Conscious Dogs Treated with α1-Adrenoceptor Antagonists 2002 ·Journal of Pharmacology and Experimental Therapeutics ·David G. Witte, Michael E. Brune, (unknown), Ivan Milicic, DeAnne Stolarik, Yu‐Hua Hui, Kennan C. Marsh, James F. Kerwin, Michael D. Meyer, Arthur A. Hancock	16
12	Functional Characterization of the Novel Neuronal Nicotinic Acetylcholine Receptor Ligand GTS-21 In Vitro and In Vivo 1997 ·Pharmacology Biochemistry and Behavior ·Clark A. Briggs, David J. Anderson, Jorge D. Brioni, Jerry J. Buccafusco, Michael Buckley, Jeffrey E. Campbell, Michael Decker, Diana L. Donnelly‐Roberts, Richard L. Elliott, Murali Gopalakrishnan, Mark W. Holladay, Yu‐Hua Hui, William James Jackson, David J.B. Kim, Kennan C. Marsh, Alyssa B. O'Neill, Mark Prendergast, Keith B. Ryther, James P. Sullivan, Stephen P. Arnerić	171
13	Development of a sensitive method for quantitation of ABT-089 in plasma using fluorescence labeling with 7-fluoro-4-nitrobenzo-2-oxa-1,3-diazole 1997 ·Journal of Chromatography B Biomedical Sciences and Applications ·Yu‐Hua Hui, (unknown), Kennan C. Marsh	4
14	Sensitive detection of selected cholinergic channel activators derivatized with 7-fluoro-4-nitrobenzo-2-oxa-1,3-diazole 1995 ·Journal of Pharmaceutical and Biomedical Analysis ·Yu‐Hua Hui, Kennan C. Marsh	5
15	10‐, 12‐, and 29‐Hydroxybullatacinones: New cytotoxic annonaceous acetogenins from nnona bullata rich (annonaceae) 1994 ·Natural Toxins ·Zhe-ming Gu, (unknown), Yu‐Hua Hui, J. L. McLaughlin	10
16	Treatment of experimental Pneumocystis carinii infection by combination of clarithromycin and sulphamethoxazole 1994 ·Journal of Antimicrobial Chemotherapy ·Jeffrey Alder, Michael J. Mitten, (unknown), Lisa E. Hernandez, Yu‐Hua Hui, Kennan C. Marsh, Jacob J. Clement	8
17	Bullatencin, 4‐deoxyasimicin, and the uvariamicins: Additional bioactive annonaceous acetogenins from Annona bullata rich. (Annonaceae) 1992 ·Natural Toxins ·Yu‐Hua Hui, Karl V. Wood, Jerry L. McLaughlin	12
18	Reticulatacin: A new bioactive acetogenin from Annona reticulata (Annonaceae) 1991 ·Tetrahedron ·(unknown), Yu‐Hua Hui, J. Kent Rupprecht, Jon E. Anderson, John F. Kozlowski, Geng‐Xian Zhao, Karl V. Wood, (unknown)	35
19	Annonaceous Acetogenins: A Review 1990 ·Journal of Natural Products ·J. Kent Rupprecht, Yu‐Hua Hui, Jerry L. McLaughlin	438
20	16α-Hydroxy-(–)-kauranoic Acid: A Selectively Cytotoxic Diterpene from Annona bullata 1990 ·Pharmaceutical Research ·Yu‐Hua Hui, Ching‐Jer Chang, David L. Smith, Jerry L. McLaughlin	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact